HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven Horwitz Selected Research

romidepsin (FK228)

1/2022Current Treatment of Peripheral T-cell Lymphoma.
10/2017Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials.
1/2017Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma.
1/2017Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial.
3/2016Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial.
1/2014Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses.
1/2014Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
2/2012Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steven Horwitz Research Topics

Disease

14Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
10/2020 - 07/2006
13Neoplasms (Cancer)
01/2022 - 03/2007
12T-Cell Lymphoma (Lymphoma, T Cell)
11/2021 - 03/2007
11Lymphoma (Lymphomas)
12/2020 - 07/2006
8Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
12/2021 - 05/2007
6Mycosis Fungoides
12/2021 - 09/2012
5Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021 - 07/2006
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2018 - 11/2010
3Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2021 - 01/2018
3Hodgkin Disease (Hodgkin's Disease)
06/2021 - 02/2012
3Neutropenia
01/2021 - 01/2018
3Hematologic Neoplasms (Hematological Malignancy)
11/2018 - 01/2006
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2013 - 04/2005
2Disease Progression
06/2021 - 09/2013
2Extranodal NK-T-Cell Lymphoma
12/2020 - 06/2013
2Diarrhea
11/2018 - 01/2018
2Thrombocytopenia (Thrombopenia)
01/2018 - 02/2016
1Symptom Flare Up
01/2021
1COVID-19
01/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Genetic Translocation (Chromosomal Translocation)
01/2020
1T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
01/2019
1Exanthema (Rash)
11/2018
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2018
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018
1Pneumonia (Pneumonitis)
01/2018
1Anemia
01/2018
1Febrile Neutropenia
02/2016
1Mucositis
02/2016
1Sepsis (Septicemia)
02/2016
1Nausea
03/2015
1Infections
01/2014
1Confusion (Bewilderment)
09/2013
1Follicular Mucinosis
09/2012
1Subcutaneous panniculitis-like T-cell lymphoma
02/2012
1Stomatitis
09/2009

Drug/Important Bio-Agent (IBA)

8romidepsin (FK228)FDA Link
01/2022 - 02/2012
510-propargyl-10-deazaaminopterinFDA Link
01/2022 - 11/2007
5Histone Deacetylase InhibitorsIBA
10/2020 - 01/2006
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 04/2005
4Vincristine (Oncovin)FDA LinkGeneric
01/2019 - 04/2005
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019 - 04/2005
4Prednisone (Sone)FDA LinkGeneric
01/2019 - 04/2005
3Brentuximab VedotinIBA
01/2022 - 03/2015
3belinostatIBA
01/2022 - 08/2015
3Pharmaceutical PreparationsIBA
06/2021 - 01/2019
3Etoposide (VP 16)FDA LinkGeneric
12/2020 - 03/2015
2mogamulizumabIBA
12/2021 - 01/2021
2Monoclonal AntibodiesIBA
01/2021 - 10/2018
2VorinostatFDA Link
01/2021 - 01/2006
2Asparaginase (Elspar)FDA Link
12/2020 - 06/2013
2Janus Kinase InhibitorsIBA
06/2020 - 01/2019
2ruxolitinibIBA
06/2020 - 01/2019
2EnzymesIBA
11/2018 - 03/2007
2Transaminases (Aminotransferases)IBA
11/2018 - 02/2016
2duvelisibIBA
11/2018 - 01/2018
2Rituximab (Mabthera)FDA Link
07/2017 - 04/2010
2Bexarotene (LGD1069)FDA Link
02/2012 - 05/2007
2Anaplastic Lymphoma KinaseIBA
11/2010 - 07/2006
2Reduced Folate Carrier ProteinIBA
09/2009 - 11/2007
1Immunomodulating AgentsIBA
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1Methotrexate (Mexate)FDA LinkGeneric
12/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2020
1IfosfamideFDA LinkGeneric
12/2020
1tofacitinibIBA
01/2019
1Formaldehyde (Formol)FDA Link
10/2018
1ParaffinIBA
10/2018
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2018
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2018
1Alanine Transaminase (SGPT)IBA
01/2018
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2018
1CreatinineIBA
02/2016
1Capsules (Microcapsules)IBA
01/2016
1Carboplatin (JM8)FDA LinkGeneric
03/2015
1Biomarkers (Surrogate Marker)IBA
02/2014
1Glia Maturation Factor (GMF)IBA
09/2013
1AnthracyclinesIBA
06/2013
1MucinsIBA
09/2012
1Proteins (Proteins, Gene)FDA Link
11/2010
1HomocysteineIBA
09/2009
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
09/2009
1Methylmalonic AcidIBA
09/2009
1Folic Acid (Vitamin M)FDA LinkGeneric
09/2009
1Interferon alpha-2 (Roferon-A)FDA Link
05/2007
1arginine butyrateIBA
03/2007
1Ganciclovir (Cytovene)FDA LinkGeneric
03/2007

Therapy/Procedure

27Therapeutics
12/2021 - 07/2006
11Drug Therapy (Chemotherapy)
01/2021 - 11/2007
3Breast Implants (Breast Implant)
01/2021 - 01/2016
2Immunotherapy
01/2021 - 01/2019
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
12/2020
1Precision Medicine
06/2020
1Aftercare (After-Treatment)
12/2018
1Combination Drug Therapy (Combination Chemotherapy)
01/2018
1Transplantation
03/2015
1Salvage Therapy
03/2015
1Radiotherapy
09/2013
1Lymph Node Excision (Lymph Node Dissection)
06/2013
1Photopheresis
10/2012